M&A Deal Summary

Navamedic Acquires Impolin

On May 5, 2022, Navamedic acquired medical products company Impolin for 50M SEK

Acquisition Highlights
  • This is Navamedic’s 1st transaction in the Medical Products sector.
  • This is Navamedic’s largest (disclosed) transaction.
  • This is Navamedic’s 1st transaction in Sweden.

M&A Deal Summary
Date 2022-05-05
Target Impolin
Sector Medical Products
Buyer(s) Navamedic
Deal Type Add-on Acquisition
Deal Value 50M SEK

Target

Impolin

Täby, Sweden
Impolin specializes in products related to the pre and post-treatment of bariatric surgery. Impolin’s portfolio includes Modifast, a range of diet and meal replacement products, and MedMade, a multivitamin and minerals tablet for post-bariatric surgery supplementation, which are products aimed at supporting patients during weight loss or obesity treatment, including bariatric surgery. Impolin is based in Täby, Sweden.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Navamedic

Oslo, Norway
Category Company
Founded 2002
Sector Life Science
Employees45
Revenue 512M NOK (2023)
DESCRIPTION

Navamedic is a pharmaceutical company, markets, and sells pharmaceuticals and other health care products in Northern European region. The company's product portfolio includes generic, branded, and patented pharmaceuticals, as well as medical devices, food supplements, cosmetics, and other health care products. Navamedic was founded in 2002 and is based in Oslo, Norway.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Sweden) 1 of 1
Year (2022) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal